This research highlights the association between AMY1 gene copy number and salivary enzyme activity, with implications for ...

The American Diabetes Association recognises remission of diabetes as an appropriate aim of management. Caution Websites advertising medicines of no proven validity with false claims of endorsement by ...

In total, there are about 50 student volunteers, along with an additional 350 volunteers registered to work on an ad hoc ...

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

A new study published June 25 in the Journal of the American Heart Association finds that fewer people are dying ... particularly obesity and diabetes, so we shouldn’t write everything off to age ...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog at American Diabetes Association's ...

Amgen (NASDAQ:AMGN) today announced full results from Part 1 of the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133), a long-acting, peptide-antibody conjugate subcutaneously ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

BURLINGTON, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes ...

Currently, fewer than half of patients with type 2 diabetes achieve optimal glycemic control on current incretin therapies. Cardioprotective effects in HFpEF - Dr. Yan's poster will show that in a ...